SCHEMBL14696901

SCHEMBL14696901

CC(=NNC(=O)c1ccc(Cl)c(Br)c1)c1cc(Cl)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 9/20 0.68
MAPT P10636 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
HTT P42858 2/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
CYP3A4 P08684 2/20 0.54
CYP2C19 P33261 2/20 0.54
BRD4 O60885 1/20 0.54
CYP2C9 P11712 1/20 0.54
BRD2 P25440 1/20 0.54
MTOR P42345 2/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
POLB P06746 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
PKM P14618 1/20 0.48
MCL1 Q07820 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14696900 1.00 KDM1A (0.68) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL684701 0.86 KDM1A (0.77) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL685115 0.86 KDM1A (0.85) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL14712676 0.83 KDM1A (0.64) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL15772845 0.83 KDM1A (0.64) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL15772844 0.83 KDM1A (0.64) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL684836 0.83 KDM1A (0.79) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL684839 0.83 KDM1A (0.83) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL683907 0.81 KDM1A (0.69) KDM1AMAPTSMN1; SMN2HTTRAB9A
SCHEMBL15772966 0.81 KDM1A (1.00) KDM1AMAPTSMN1; SMN2HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744330-B1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIV UTAH RES FOUND (US) 2020-07-15 EP disclosed
EP-3010915-B1 SUBSTITUTED (3-(5-CHLORO-2-HYDROXYPHENYL)-1-BENZOYL-1H-PYRAZOLE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2019-05-08 EP disclosed
US-9642857-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-05-09 US disclosed
US-9555024-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-31 US disclosed
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2016-05-05 US disclosed
US-9266838-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2016-02-23 US disclosed
US-20150150864-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-06-04 US disclosed
US-8987335-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-03-24 US disclosed
EP-2744330-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS University Of Utah Research Foundation (US) 2014-06-25 EP disclosed
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH (US) 2014-06-12 US disclosed
WO-2013025805-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2013-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150150864-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885MAPT 1088/4885SMN1; SMN2 1095/4885
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885MAPT 1088/4885SMN1; SMN2 1095/4885
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS DOT1L, NSD1, KDM1B KDM1A 7/4885MAPT 3924/4885SMN1; SMN2 1733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.